Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Oncology

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2016.3558PMID 27278553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells.

  2015cited by this paper
• Oxidative stress and cancer: an overview.

  2013cited by this paper
• Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis

  2013cited by this paper
• Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.

  2013cited by this paper
• Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or Docetaxel

  2012cited by this paper
• Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models

  2012cited by this paper
• Apoptosis in cancer: from pathogenesis to treatment

  2011cited by this paper
• The essential role of evasion from cell death in cancer.

  2011cited by this paper
• Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies.

  2011cited by this paper
• Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.

  2011cited by this paper
• Silencing of Bmi-1 gene by RNA interference enhances sensitivity to doxorubicin in breast cancer cells.

  2011cited by this paper
• Bcl-2 proteins and mitochondria--specificity in membrane targeting for death.

  2011cited by this paper
• Loss of manganese superoxide dismutase leads to abnormal growth and signal transduction in mouse embryonic fibroblasts.

  2010cited by this paper
• Molecular pathways linking inflammation and cancer.

  2010cited by this paper
• TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters

  2010cited by this paper
• The BCL-2 family reunion.

  2010cited by this paper
• Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin.

  2009cited by this paper
• Regulation of superoxide dismutase genes: implications in disease.

  2009cited by this paper
• Cell Cycle Arrest Induced by Hydrogen Peroxide Is Associated with Modulation of Oxidative Stress Related Genes in Breast Cancer Cells

  2009cited by this paper
• Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin.

  2009cited by this paper
• Antiproliferative property and apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells.

  2008cited by this paper
• All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-kappaB.

  2008cited by this paper
• Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells

  2008cited by this paper
• Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells.

  2007cited by this paper
• P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells

  2007cited by this paper
• Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata.

  2006cited by this paper
• Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.

  2005cited by this paper
• Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives.

  2005cited by this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cited by this paper
• Tumor Suppressive Effects of MnSOD Overexpression May Involve Imbalance in Peroxide Generation Versus Peroxide Removal

  2004cited by this paper
• Drug‐resistant breast carcinoma (MCF‐7) cells are paradoxically sensitive to apoptosis

  2004cited by this paper
• Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy.

  2004cited by this paper
• Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase.

  2003cited by this paper
• Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65

  2003cited by this paper
• Reactive oxygen species in oncogenic transformation.

  2003cited by this paper
• Caspase‐3 is not essential for DNA fragmentation in MCF‐7 cells during apoptosis induced by the pyrrolo‐1,5‐benzoxazepine, PBOX‐6

  2002cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2002cited by this paper
• Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide.

  2002cited by this paper
• Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

  2001cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2001cited by this paper
• Apoptosis in the absence of caspase 3

  2001cited by this paper
• Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels

  2000cited by this paper
• Caspase‐8 in Apoptosis: The Beginning of “The End”?

  2000cited by this paper
• [Mitochondria and apoptosis].

  2000cited by this paper
• Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.

  1999cited by this paper
• Emerging roles of caspase-3 in apoptosis

  1999cited by this paper
• Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation.

  1998cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.

  1998cited by this paper
• Programmed cell death in animal development.

  1997cited by this paper
• Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression

  1996cited by this paper
• BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.

  1996cited by this paper
• Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

  1994cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• The role of the cellular antioxidant defense in oxidant carcinogenesis.

  1994cited by this paper
• Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

  1991cited by this paper
• Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.

  1989cited by this paper

• Methyl divanillate enhances doxorubicin efficacy in TNBC cell lines through redox imbalance and apoptotic reprogramming.

  2026cites this paper
• E2F1 K117 methylation by SETD6 disrupts BRD4–E2F1 binding and modulates E2F1 chromatin binding and gene regulation in prostate cancer cells

  2026cites this paper
• A detoxified exosome–ECM hydrogel depot for localized and sustained chemotherapy in prostate cancer

  2026cites this paper
• Anticancer and anti-inflammatory potentials of doped CuO and ZnO nanoparticles: a multi-pathway mechanistic study

  2026cites this paper
• Oxidative stress-mediated responses in endometrial cancer cells: contrasting effects of doxorubicin and menadione

  2026cites this paper
• Empagliflozin mitigates doxorubicin-induced nephrotoxicity by modulating sirtuin 1, nuclear factor-κB/tumor necrosis factor-α, and cleaved caspase-3 pathways without compromising its cytotoxic efficacy.

  2026cites this paper
• Selective Cytotoxicity of Ozone in Burkitt and Mantle Cell Lymphomas: Disruption of AURKA/B Pathways and Induction of Apoptosis

  2026cites this paper
• The role of mitochondrial dysfunction in the cytotoxic synergistic effect of gemcitabine and arsenic on breast cancer

  2025cites this paper
• Dynamic full-field swept-source optical coherence tomography for high-resolution, long-depth, and intratissue-activity imaging

  2025cites this paper
• Low-dose radiation ameliorates doxorubicin-induced renal injury via reducing oxidative stress and protecting mitochondrial function

  2025cites this paper
• Targeting Oxidative Stress Biomarkers in Breast Cancer Development and the Potential Protective Effect of Phytochemicals

  2025cites this paper
• Novel combinational nanomedicines, liposomes, to tackle breast cancer

  2025cites this paper
• Evaluation of Anticancer Potential of Ganoderma lucidum on MCF-7 Breast Cancer Cells Through Genetic Transcription of Energy Metabolism

  2025cites this paper
• Green synthesis and multifunctional performance of Cu/TiO 2 nanoparticles from Beta vulgaris leaf extract for diclofenac degradation and biomedical applications

  2025cites this paper
• Folic acid-modified chitosan nanoparticles for targeted delivery of a binuclear Co(II) complex in cancer therapy.

  2025cites this paper
• Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer

  2025influential citation
• Silencing of lncRNA HOTAIR enhances doxorubicin sensitivity and induces apoptosis in diffuse large B-cell lymphoma cells.

  2025cites this paper
• Meme Kanseri Hücresinde Metilen Mavisi Aracili Fotodinamik Terapi ve Doksorubisinin Kombinasyonel Etkisi

  2025cites this paper
• Novel nanographene oxide conjugates as stimuli-responsive theranostic tool for cancer

  2025cites this paper
• Synthesis and Anticancer Activity Evaluation of New 5-((5-Nitrofuran-2-yl)allylidene)-2-thioxo-4-thiazolidinones

  2025cites this paper
• Rhoifolin potentiates the anti-cancer activity of doxorubicin in MDA-MB-231 triple-negative breast cancer cells

  2025cites this paper
• Genistein Improves the Cytotoxic, Apoptotic, and Oxidative-Stress-Inducing Properties of Doxorubicin in SK-MEL-28 Cancer Cells

  2025cites this paper
• Synergistic anticancer effect of Doxorubicin and Tamoxifen in chitosan nanoparticles for ER-positive breast cancer

  2025cites this paper
• Hydrogen peroxide and cisplatin regulate the ROS/PKM2 pathway to affect the growth of cancer.

  2025cites this paper
• Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds

  2025cites this paper
• Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO

  2025cites this paper
• Cyclin-dependent kinase inhibitor abemaciclib-induced cutaneous responses mediated by inflammation.

  2025cites this paper
• Anti-leukemia activity of the ethyl acetate extract from Gynostemma pentaphyllum (Thunb.) leaf against FLT3-overexpressing AML cells and its phytochemical characterization

  2025cites this paper
• Sanguinarine and Doxorubicin Inhibit Heat Shock Protein HSPA5 and Trigger ER Stress in Breast Cancer.

  2025cites this paper
• Breast cancer preclinical models: a vital resource for comprehending disease mechanisms and therapeutic development

  2025cites this paper
• Telomerase inhibitors TMPyP4 and BIBR 1532 show synergistic antitumor activity in combination with chemotherapeutic drugs

  2025cites this paper
• HERPUD1 mediates palmitic acid-induced UPR sustaining TNBC aggressiveness and is destabilized by CK2 pharmacological inhibition

  2025cites this paper
• Evaluating the antioxidant-mediated neuroprotection of hamamelitannin against H₂O₂-induced oxidative damage

  2025cites this paper
• Synthesis and anti-cancer biological evaluation of a novel protoapigenone analogue, WYC-241.

  2025cites this paper
• The involvement of exosomes in the tumorigenicity of breast cancer cell lines through the crosstalk between STAT3, Notch, and Wnt signaling pathways

  2025cites this paper
• Caffeine Modulates Cell Death and Telomerase Activity in Triple-negative Breast Cancer Cells

  2025cites this paper
• Blackberry-Like Doxorubicin Loaded Hyaluronic Acid/Zinc Phthalocyanine Loaded Mesoporous Silica Nanocomposites for Long-Term Tumor Photodynamic and Chemotherapy Synergistic Therapy

  2025cites this paper
• Hyperthermia and Chemotherapy Combination in Triple-Negative Breast Cancer Cells

  2025cites this paper
• Sigma receptors and mitochondria-associated ER membranes are converging therapeutic targets for Alzheimer’s disease

  2025cites this paper
• SYNERGISTIC ANTICANCER EFFECTS OF DOXORUBICIN IN COMBINATION WITH TILORONE IN BREAST CANCER.

  2025cites this paper
• Self-oxygenating GMZ@HA nanocarriers enhance doxorubicin cytotoxicity in hypoxic breast cancer

  2025cites this paper
• Microbubble-Templated Immunoactive Metal-Phenolic Capsules for Drug Delivery and Enhanced Cancer Immunotherapy

  2025cites this paper
• Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity

  2025cites this paper
• Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma

  2025cites this paper
• 3-Hydroxy-β-ionone Suppresses Breast Cancer Progression by Inducing Apoptosis and Blocking EMT Through the TGF-β/Smad Signaling Pathway

  2025cites this paper
• Engineering copper (II) in situ reduction and delivery by a novel amphiphilic diacylhydrazone for chemodynamic therapy.

  2025cites this paper
• Chemotherapy of breast cancer cells alters susceptibility to complement-mediated opsonization and killing

  2025cites this paper
• From seed to bioactive: unveiling sprouting-driven changes in chickpeas via targeted metabolomics and in silico modelling.

  2025cites this paper
• Doxorubicin and 4-nitrochalcone loaded in beeswax-based nanostructured lipid carriers: In vitro antitumoral screening and evaluation of synergistic effect on HepG-2 cells.

  2024cites this paper
• Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer.

  2024cites this paper
• Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy

  2024cites this paper
• Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies.

  2024cites this paper
• Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer.

  2024cites this paper
• Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21

  2024cites this paper
• Predictive bioactivity of compounds from Vitis gracilis leaf extract to counteract doxorubicin-induced cardiotoxicity via sirtuin 1 and adenosine monophosphate-activated protein kinase: An in-silico study

  2024cites this paper
• Insights into molecular mechanisms of chemotherapy resistance in cancer

  2024cites this paper
• Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: in vitro study on apoptosis.

  2024cites this paper
• Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology

  2024cites this paper
• Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo

  2024cites this paper
• Evaluation of Oxidative Stress, Anti-Oxidant, Vitamins and Co-Factor Elements in The Sera of Gastric Cancer in Iraqi Patients

  2024cites this paper
• Co-culture system of breast cancer and normal cells to investigate inflammation: using doxorubicin encapsulated in adipose-derived exosomes

  2024cites this paper
• Fabrication of curcumin-loaded nano-micelles based on quercetin-quarternary ammonium-chitosan (Qu-QCS) conjugate and evaluation of synergistic effect with doxorubicin against breast cancer.

  2024cites this paper
• In situ growth of ZIF-8 on Cellulose microspheres with high doxorubicin loading capacity and pH-sensitive for oral drug delivery

  2024cites this paper
• Oxygen Nanobubbles Halt Tumor Aggression and Metastasis by Inhibiting Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Lung and Mammary Adenocarcinoma

  2024cites this paper
• Silanization Improves the Performance of Reduced Graphene Oxide as Biomaterial for Drug Delivery Applications

  2024cites this paper
• Exploiting Response Surface Methodology to Engineer the Mechanical Properties of Alginate‐based Hydrogels

  2024cites this paper
• Injectable pH-responsive polypeptide hydrogels for local delivery of doxorubicin

  2024cites this paper
• Ultra-diluted/dynamized doxorubicin reduces the toxicity caused by doxorubicin during the in vitro culture of pig preantral follicles enclosed in ovarian tissue.

  2024cites this paper
• Intravascular Casting Radiopaque Hydrogel Systems for Transarterial Chemo/Cascade Catalytic/Embolization Therapy of Hepatocellular Carcinoma.

  2024cites this paper
• Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicity

  2024cites this paper
• Failure to progress: breast and prostate cancer cell lines in developing targeted therapies

  2024cites this paper
• TPT disrupts early embryonic development and glucose metabolism of marine medaka in different salinites.

  2024cites this paper
• Melatonin and Metformin Mitigate Doxorubicin-Induced Alveolar Bone Toxicity

  2024cites this paper
• Photoactive ruthenium polypyridine cage incorporating doxorubicin: Synthesis, photorelease, and photocytotoxicity of doxorubicin with blue light

  2024cites this paper
• Doxorubicin-induced neurotoxicity differently affects the hippocampal formation subregions in adult mice

  2024cites this paper
• Microfluidic synthesis of hemin@ZIF-8 nanozyme with applications in cellular reactive oxygen species detection and anticancer drug screening.

  2024cites this paper
• Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review

  2024cites this paper
• The ameliorative effect of rosmarinic acid and epigallocatechin gallate against doxorubicin-induced genotoxicity

  2024cites this paper
• Evaluation of In Vitro Biological Activity of Flavanone/Chromanone Derivatives: Molecular Analysis of Anticancer Mechanisms in Colorectal Cancer

  2024cites this paper
• Anethole Alleviates Doxorubicin-Induced Cardiac and Renal Toxicities: Insights from Network Pharmacology and Animal Studies.

  2024cites this paper
• Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM

  2024cites this paper
• cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer

  2024cites this paper
• Investigation of Molecular Mechanisms Involved in Sensitivity to the Anti-Cancer Activity of Costunolide in Breast Cancer Cells

  2023cites this paper
• Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity

  2023cites this paper
• Metabolic Health, Mitochondrial Fitness, Physical Activity, and Cancer

  2023cites this paper
• RNA methylation and cellular response to oxidative stress-promoting anticancer agents

  2023cites this paper
• Development of "smart" drug delivery systems for chemo/PDT synergistic treatment.

  2023cites this paper
• Hypoxic volatile metabolic markers in the MDA-MB-231 breast cancer cell line

  2023influential citation
• Narirutin. A flavonoid found in citrus fruits modulates cell cycle phases and inhibits the proliferation of hormone-refractory prostate cancer cells by targeting hyaluronidase.

  2023cites this paper
• Evaluation of the Total Oxidant Status to the Antioxidant Capacity Ratio as a Valuable Biomarker in Breast Cancer Patients.

  2023cites this paper
• Folic acid-modified biocompatible Pullulan/Poly(acrylic acid) nanogels for targeted delivery to MCF-7 cancer cells.

  2023cites this paper
• M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer

  2023cites this paper
• Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment

  2023cites this paper
• A comparative analysis of daunorubicin and its metabolite daunorubicinol interaction with apoptotic and drug resistance proteins using in silico approach

  2023cites this paper
• Non-Response of Epstein–Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases

  2023cites this paper
• Cytotoxic effect of Ziziphus Spina-Christi extract alone and in combination with doxorubicin on breast cancer cells

  2023cites this paper
• Cytotoxic, antioxidant, and cytoprotective properties of polyphenol‐enriched extracts from pecan nutshells in MDA‐MB‐231 breast cancer cells

  2023cites this paper
• Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?

  2023cites this paper
• Bee Pollen and Doxorubicin by Synergistic Effects Inhibit the Proliferation of Breast Tumors in 4T1 Tumor-bearing BALB/c Mice: A Biochemical, Immunohistochemical,and Molecular Approach

  2023cites this paper
• Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells

  2023cites this paper